Cresco Labs (CRLBF) Non-Current Assets (2019 - 2026)
Cresco Labs (CRLBF) reported Non-Current Assets of $952.2 million for Q1 2026, down 9.57% on a YoY basis from $1.1 billion in Q1 2025, and up 1.51% quarter-over-quarter from $938.0 million in Q4 2025.
Cresco Labs (CRLBF) Non-Current Assets (2019 - 2026) Analysis & Trends
Cresco Labs has reported Non-Current Assets for 8 years, with the latest figure at $952.2 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Assets fell 9.57% year-over-year to $952.2 million; the trailing twelve-month figure through Mar 2026 stood at $952.2 million (down 9.57% YoY), and the FY2025 full-year result was $938.0 million, down 11.6% from the prior year.
- Non-Current Assets for Q1 2026 stood at $952.2 million, up from $938.0 million in the prior quarter.
- The five-year high for Non-Current Assets was $1.4 billion in Q3 2022, with the low at $938.0 million in Q4 2025.
- Historically, Non-Current Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
- Annual changes were most pronounced in 2022 — Non-Current Assets surged 35.08% — and 2023, when it fell 21.78%.
- Cresco Labs' Non-Current Assets stood at $1.3 billion in 2022, then retreated by 14.1% to $1.1 billion in 2023, then decreased by 1.78% to $1.1 billion in 2024, then fell by 11.6% to $938.0 million in 2025, then climbed by 1.51% to $952.2 million in 2026.
- The last three Non-Current Assets figures came in at $952.2 million (Q1 2026), $938.0 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 952.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 952.19 Mn |
| Dec 31, 2025 | 938.03 Mn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.03 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.06 Bn |
| Sep 30, 2024 | 1.07 Bn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 1.07 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.10 Bn |
| Jun 30, 2023 | 1.25 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.26 Bn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.39 Bn |
| Mar 31, 2022 | 1.39 Bn |
| Dec 31, 2021 | 1.36 Bn |
| Sep 30, 2021 | 1.12 Bn |
| Mar 31, 2021 | 1.03 Bn |